William Blair & Company’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,566
| Closed | -$87.8K | – | 1859 |
|
|
2024
Q3 | $87.8K | Sell |
10,566
-85,052
| -89% | -$707K | ﹤0.01% | 1555 |
|
|
2024
Q2 | $685K | Sell |
95,618
-3,156
| -3% | -$22.6K | ﹤0.01% | 992 |
|
|
2024
Q1 | $856K | Sell |
98,774
-2,188
| -2% | -$19K | ﹤0.01% | 918 |
|
|
2023
Q4 | $661K | Sell |
100,962
-165,298
| -62% | -$1.08M | ﹤0.01% | 991 |
|
|
2023
Q3 | $2.66M | Sell |
266,260
-118,632
| -31% | -$1.19M | 0.01% | 588 |
|
|
2023
Q2 | $4.78M | Sell |
384,892
-219,152
| -36% | -$2.72M | 0.02% | 462 |
|
|
2023
Q1 | $8.46M | Sell |
604,044
-265,277
| -31% | -$3.72M | 0.03% | 333 |
|
|
2022
Q4 | $12.4M | Buy |
869,321
+81,077
| +10% | +$1.16M | 0.05% | 270 |
|
|
2022
Q3 | $20.1M | Buy |
788,244
+96,045
| +14% | +$2.45M | 0.09% | 182 |
|
|
2022
Q2 | $19.7M | Sell |
692,199
-16,201
| -2% | -$460K | 0.09% | 197 |
|
|
2022
Q1 | $25M | Sell |
708,400
-4,348
| -0.6% | -$153K | 0.09% | 198 |
|
|
2021
Q4 | $29.9M | Sell |
712,748
-456,532
| -39% | -$19.1M | 0.09% | 192 |
|
|
2021
Q3 | $57.4M | Buy |
1,169,280
+196,650
| +20% | +$9.65M | 0.2% | 118 |
|
|
2021
Q2 | $40.6M | Buy |
972,630
+462,000
| +90% | +$19.3M | 0.14% | 152 |
|
|
2021
Q1 | $18.2M | Buy |
510,630
+477,576
| +1,445% | +$17M | 0.07% | 227 |
|
|
2020
Q4 | $927K | Buy |
+33,054
| New | +$927K | ﹤0.01% | 873 |
|